JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB209439

PE Anti-VEGFA antibody [EP1176Y]

Be the first to review this product! Submit a review

|

(3 Publications)

Rabbit Recombinant Monoclonal VEGFA antibody - conjugated to PE. Suitable for Flow Cyt (Intra), ICC/IF, IHC-P and reacts with Human, Mouse samples. Cited in 3 publications.

View Alternative Names

VEGF, VEGFA, L-VEGF, Vascular permeability factor, VPF

2 Images
Immunocytochemistry/ Immunofluorescence - PE Anti-VEGFA antibody [EP1176Y] (AB209439)
  • ICC/IF

Lab

Immunocytochemistry/ Immunofluorescence - PE Anti-VEGFA antibody [EP1176Y] (AB209439)

Immunofluorescent analysis of 4% Paraformaldehyde-fixed, 0.1% TritonX-100 permeabilized HeLa (human cervical adenocarcinoma epithelial cell) cells labelling VEGFA with ab209439 at 1/50 dilution (Magenta).

Confocal image showing cytoplasmic staining in HeLa cell line (shown in green). The counterstain was observed in magenta. Nuclear DNA was labelled with DAPI (shown in blue). Image was taken with a confocal microscope (Leica-Microsystems, TCS SP8).

ab195887 Anti-alpha Tubulin mouse monoclonal antibody - Microtubule Marker (Alexa Fluor® 488) was used to counterstain tubulin at 1/200 dilution (Green).

Flow Cytometry (Intracellular) - PE Anti-VEGFA antibody [EP1176Y] (AB209439)
  • Flow Cyt (Intra)

Unknown

Flow Cytometry (Intracellular) - PE Anti-VEGFA antibody [EP1176Y] (AB209439)

Overlay histogram showing HeLa cells stained with ab209439 (red line). The cells were fixed with 4% formaldehyde (10 min) and then permeabilized with 90% methanol at -20°C for 15 min. The cells were then incubated in 1x PBS / 10% normal goat serum to block non-specific protein-protein interactions followed by the antibody (ab209439, 1/2500 dilution) for 30 min at 22°C.

Isotype control antibody (black line) was rabbit IgG (monoclonal) Phycoerythrin (ab209478) used at the same concentration and conditions as the primary antibody. Unlabelled sample (blue line) was also used as a control.

Acquisition of >5,000 events were collected using a 20 mW Solid State Blue Laser (488nm) and 585/40 bandpass filter.

Key facts

Host species

Rabbit

Clonality

Monoclonal

Clone number

EP1176Y

Isotype

IgG

Conjugation

PE

Excitation/Emission

Ex: 480;565nm, Em: 578nm

Carrier free

No

Reacts with

Human, Human, Mouse

Applications

IHC-P, ICC/IF, Flow Cyt (Intra)

applications

Immunogen

The exact immunogen used to generate this antibody is proprietary information.

style
left-column

Alternative Products

Primary Antibodies

AB83132

Biotin Anti-VEGFA antibody

Sandwich ELISA - Biotin Anti-VEGFA antibody (AB83132)

  • 0
  • 0
Primary Antibodies

AB209835

Anti-VEGFA antibody

Lab Essentials

IHC - Wholemount - Anti-VEGFA antibody (AB209835)

  • 0
  • 0
Primary Antibodies

AB183100

Anti-VEGFA antibody

Lab Essentials

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-VEGFA antibody (AB183100)

  • 1
  • 1
Primary Antibodies

AB155944

Anti-VEGFA antibody [16F1]

Lab Essentials

Immunocytochemistry - Anti-VEGFA antibody [16F1] (AB155944)

  • 0
  • 0
Primary Antibodies

AB1316

Anti-VEGFA antibody [VG-1]

BOND RX™ Validated|Lab Essentials|Trial Size

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-VEGFA antibody [VG-1] (AB1316)

  • 4
  • 45
Primary Antibodies

AB46154

Anti-VEGFA antibody

Lab Essentials

Western blot - Anti-VEGFA antibody (AB46154)

  • 5
  • 29
Primary Antibodies

AB27620

Anti-VEGFA antibody [SP28], prediluted

RabMAb|Recombinant|Lab Essentials

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-VEGFA antibody [SP28], prediluted (AB27620)

  • 4
  • 2
Primary Antibodies

AB213244

Anti-VEGFA antibody [EPR21219]

BOND RX™ Validated|Recombinant|Lab Essentials|20ul selling size

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-VEGFA antibody [EPR21219] (AB213244)

  • 0
  • 2
Primary Antibodies

AB39250

Anti-VEGFA antibody

Immunocytochemistry/ Immunofluorescence - Anti-VEGFA antibody (AB39250)

  • 4
  • 1
Primary Antibodies

AB229377

Anti-VEGFA antibody [EPR20705] - BSA and Azide free

RabMAb|Recombinant

Western blot - Anti-VEGFA antibody [EPR20705] - BSA and Azide free (AB229377)

  • 0
  • 0
Primary Antibodies

AB214424

Anti-VEGFA antibody [EPR20705]

RabMAb|Recombinant|Lab Essentials|20ul selling size

Western blot - Anti-VEGFA antibody [EPR20705] (AB214424)

  • 0
  • 0

Complementary Products

Assay Kits

AB222510

Human VEGF ELISA Kit

SimpleStep

ELISA - Human VEGF ELISA Kit (AB222510)

  • 5
  • 1
Secondary Antibodies

AB150077

Goat Anti-Rabbit IgG H&L (Alexa Fluor® 488)

Immunocytochemistry/ Immunofluorescence - Goat Anti-Rabbit IgG H&L (Alexa Fluor® 488) (AB150077)

  • 5
  • 20
Primary Antibodies

AB195028

Alexa Fluor® 488 Anti-Von Willebrand Factor antibody [EPSISR15]

RabMAb|Recombinant

Immunocytochemistry/ Immunofluorescence - Alexa Fluor® 488 Anti-Von Willebrand Factor antibody [EPSISR15] (AB195028)

  • 5
  • 1
Primary Antibodies

AB9485

Anti-GAPDH antibody - Loading Control

BOND RX™ Validated|Lab Essentials

Immunocytochemistry/ Immunofluorescence - Anti-GAPDH antibody - Loading Control (AB9485)

  • 5
  • 88
Primary Antibodies

AB15580

Anti-Ki67 antibody

BOND RX™ Validated|KO Validated

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-Ki67 antibody (AB15580)

  • 5
  • 230
style
left-column

Reactivity data

{ "title": "Reactivity Data", "filters": { "stats": ["", "Species", "Dilution Info", "Notes"], "tabs": { "all-applications": {"fullname" : "All Applications", "shortname": "All Applications"}, "FlowCytIntra" : {"fullname" : "Flow Cytometry (Intracellular)", "shortname":"Flow Cyt (Intra)"}, "ICCIF" : {"fullname" : "Immunocytochemistry/ Immunofluorescence", "shortname":"ICC/IF"}, "IHCP" : {"fullname" : "Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections)", "shortname":"IHC-P"} }, "product-promise": { "all": "all", "testedAndGuaranteed": "tested", "guaranteed": "expected", "predicted": "predicted", "notRecommended": "not-recommended" } }, "values": { "Human": { "FlowCytIntra-species-checked": "testedAndGuaranteed", "FlowCytIntra-species-dilution-info": "1/2500", "FlowCytIntra-species-notes": "<p>The cellular localisation of this product has been verified in ICC/IF.</p>", "ICCIF-species-checked": "guaranteed", "ICCIF-species-dilution-info": "", "ICCIF-species-notes": "<p></p>", "IHCP-species-checked": "guaranteed", "IHCP-species-dilution-info": "", "IHCP-species-notes": "<p></p>" }, "Mouse": { "FlowCytIntra-species-checked": "guaranteed", "FlowCytIntra-species-dilution-info": "", "FlowCytIntra-species-notes": "<p></p>", "ICCIF-species-checked": "guaranteed", "ICCIF-species-dilution-info": "", "ICCIF-species-notes": "<p></p>", "IHCP-species-checked": "predicted", "IHCP-species-dilution-info": "", "IHCP-species-notes": "" } } }
style
left-column

Product details

Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.

What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:

  • - High batch-to-batch consistency and reproducibility
  • - Improved sensitivity and specificity
  • - Long-term security of supply
  • - Animal-free batch production

For more information, read more on recombinant antibodies.

style
left-column

Properties and storage information

Form
Liquid
Purification technique
Affinity purification Protein A
Storage buffer
pH: 7.4 Preservative: 0.02% Sodium azide Constituents: PBS, 1% BSA
Shipped at conditions
Blue Ice
Appropriate short-term storage conditions
+4°C
Appropriate long-term storage conditions
+4°C
Aliquoting information
Upon delivery aliquot
Storage information
Do Not Freeze|Store in the dark
style
left-column

Supplementary information

This supplementary information is collated from multiple sources and compiled automatically.

Vascular endothelial growth factor A (VEGFA) also known as VEGF or vascular permeability factor (VPF) is a protein that plays a central role in angiogenesis as well as in the growth of blood vessels. The molecular weight of VEGFA varies depending on the isoform typically ranging from 34 to 42 kDa. VEGFA is expressed in many tissues including fibroblasts macrophages endothelial cells and platelets. Its expression levels can increase in response to stimuli like hypoxia or inflammatory cytokines. VEGFA is an important target in research for therapies related to vascular diseases and cancer.
Biological function summary

VEGFA functions by promoting the proliferation and migration of vascular endothelial cells. It operates both as a homodimer and as part of complex signaling cascades interacting with VEGF receptors on cell surfaces to trigger downstream signals for angiogenesis. This includes endothelial cell growth migration and the new blood vessel formation process. VEGFA's activity is important for physiological processes such as wound healing and embryonic development and it also contributes to pathological conditions through its unregulated expression in diseases.

Pathways

Many processes involve VEGFA including the PI3K/AKT pathway and the MAPK/ERK pathway. These pathways regulate cell survival growth and differentiation. Other proteins like PLGF (placenta growth factor) and VEGFB often accompany VEGFA in these pathways aiding in distinct but overlapping roles. These interactions are transmitted through binding to VEGF receptors such as VEGFR-1 and VEGFR-2 subsequently activating various signaling cascades necessary for cellular and tissue homeostasis.

VEGFA relates to cancer and age-related macular degeneration among others. In cancer overexpression of VEGFA can lead to excessive angiogenesis supplying blood to tumors and facilitating tumor growth. In age-related macular degeneration upregulation of VEGFA contributes to the progression of the disease by promoting the formation of abnormal blood vessels under the retina. Anti-VEGFA therapies such as anti-VEGF antibodies (e.g. bevacizumab) can target these overexpressed pathways. VEGFA interacts with other proteins like HIF-1α which regulates its expression under hypoxia a common condition in tumors.
style
left-column
style
left-column

Product protocols

For this product, it's our understanding that no specific protocols are required. You can visit:
style
left-column

Target data

N-VEGF. Participates in the induction of key genes involved in the response to hypoxia and in the induction of angiogenesis such as HIF1A (PubMed : 35455969). Involved in protecting cells from hypoxia-mediated cell death (By similarity).. VEGFA. Growth factor active in angiogenesis, vasculogenesis and endothelial cell growth (PubMed : 34530889). Induces endothelial cell proliferation, promotes cell migration, inhibits apoptosis and induces permeabilization of blood vessels. Binds to the FLT1/VEGFR1 and KDR/VEGFR2 receptors, heparan sulfate and heparin. Binds to the NRP1/neuropilin-1 receptor. Binding to NRP1 initiates a signaling pathway needed for motor neuron axon guidance and cell body migration, including for the caudal migration of facial motor neurons from rhombomere 4 to rhombomere 6 during embryonic development (By similarity). Also binds the DEAR/FBXW7-AS1 receptor (PubMed : 17446437).. Isoform VEGF165B. Binds to the KDR receptor but does not activate downstream signaling pathways, does not activate angiogenesis and inhibits tumor growth.
See full target information VEGFA
style
left-column

Publications (3)

Recent publications for all applications. Explore the full list and refine your search

International journal of molecular sciences 26: PubMed40141292

2025

Thieno[2,3-]pyridines as a Novel Strategy Against Cervical Cancer: Mechanistic Insights and Therapeutic Potential.

Applications

Unspecified application

Species

Unspecified reactive species

Monika Čikeš Botić,Sandra Marijan,Mila Radan,Ivana Novak,Mateo Glumac,Lisa I Pilkington,Zdravko Odak,David Barker,Jóhannes Reynisson,Vedrana Čikeš Čulić

Communications biology 2:386 PubMed31646189

2019

Cancer-derived small extracellular vesicles promote angiogenesis by heparin-bound, bevacizumab-insensitive VEGF, independent of vesicle uptake.

Applications

Unspecified application

Species

Unspecified reactive species

Song Yi Ko,WonJae Lee,Hilary A Kenny,Long H Dang,Lee M Ellis,Eric Jonasch,Ernst Lengyel,Honami Naora

Science (New York, N.Y.) 361:594-599 PubMed30093597

2018

Single-cell transcriptomes from human kidneys reveal the cellular identity of renal tumors.

Applications

Unspecified application

Species

Unspecified reactive species

Matthew D Young,Thomas J Mitchell,Felipe A Vieira Braga,Maxine G B Tran,Benjamin J Stewart,John R Ferdinand,Grace Collord,Rachel A Botting,Dorin-Mirel Popescu,Kevin W Loudon,Roser Vento-Tormo,Emily Stephenson,Alex Cagan,Sarah J Farndon,Martin Del Castillo Velasco-Herrera,Charlotte Guzzo,Nathan Richoz,Lira Mamanova,Tevita Aho,James N Armitage,Antony C P Riddick,Imran Mushtaq,Stephen Farrell,Dyanne Rampling,James Nicholson,Andrew Filby,Johanna Burge,Steven Lisgo,Patrick H Maxwell,Susan Lindsay,Anne Y Warren,Grant D Stewart,Neil Sebire,Nicholas Coleman,Muzlifah Haniffa,Sarah A Teichmann,Menna Clatworthy,Sam Behjati
View all publications
style
left-column
style
left-column
style
right-column

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com